Acta otorrinolaringologica espanola最新文献

{"title":"Decision-making in Petrous Bone Cholesteatoma (PBC): Surgical options according to PBC classification","authors":"Monica Rueda Vega ,&nbsp;Montserrat Asensi-Diaz ,&nbsp;Carolina López Granados ,&nbsp;Carlos Martín Oviedo ,&nbsp;Ignacio Arístegui Torrano ,&nbsp;Miguel Arístegui Ruiz","doi":"10.1016/j.otorri.2025.512277","DOIUrl":"10.1016/j.otorri.2025.512277","url":null,"abstract":"<div><h3>Introduction</h3><div>Petrous bone cholesteatoma (PBC) is a rare, potentially life-threatening condition requiring surgical management to prevent severe complications. While classification systems, such as Sanna’s, are widely used to guide surgical planning, actual decision-making is often influenced by additional clinical factors beyond lesion type.</div></div><div><h3>Material and methods</h3><div>A retrospective analysis of 94 PBCs in 92 patients operated between 1995 and 2024 was conducted. Data included demographics, clinical presentation, PBC classification, surgical approach, use of endoscopic assistance, recurrence, follow-up, and hearing rehabilitation. The aim of this study is to describe the surgical strategies applied to different PBC types in a series of 94 cases, evaluate the practical utility of classification systems, and propose a decision-making approach based on inner ear involvement and other critical factors</div></div><div><h3>Results</h3><div>The most common PBC type was supralabyrinthine (40.43%), followed by massive (18.09%) and retrolabyrinthine-infralabyrinthine (11.7%). A total of 102 surgeries were performed using various approaches, including modified translabyrinthine (24.51%), subtotal petrosectomy (22.55%), and transotic approach (18.63%). Endoscopic assistance was used in 11 cases. Recurrence occurred in 8.51% of cases, with a median follow-up of 48.5 months. Cochlear implantation was used in 8 patients and bone conduction implants in 3.</div></div><div><h3>Conclusions</h3><div>PBC classification provides valuable insights for understanding lesion behavior and planning surgery, but it is insufficient alone for determining the optimal surgical approach. Decisions must be individualized, considering hearing status, inner ear and facial nerve involvement, contralateral ear function, lesion extension, and anatomical factors. A classification-based strategy complemented by these considerations ensures safer and more effective management of PBC.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 6","pages":"Article 512277"},"PeriodicalIF":1.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-life outcomes of benralizumab treatment in chronic rhinosinusitis with nasal polyps: The BenREALizumab study","authors":"Juan Maza-Solano ,&nbsp;Vicente Merino-Bohórquez ,&nbsp;Ana Gómez-Bastero ,&nbsp;Julio Delgado-Romero ,&nbsp;Serafín Sánchez-Gomez","doi":"10.1016/j.otorri.2025.512291","DOIUrl":"10.1016/j.otorri.2025.512291","url":null,"abstract":"<div><div>Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease with a significant impact on quality of life. Benralizumab has shown efficacy in severe eosinophilic asthma, but there is limited evidence for CRSwNP. A prospective observational study was conducted in a tertiary hospital with six adults with severe CRSwNP, according to EPOS2020 criteria, treated for 52 weeks. All had multiple surgeries (mean 3.3) and high cumulative exposure to systemic corticosteroids. Initially, they presented a high symptom and endoscopic burden (SNOT-22: 72; NPS: 5.2). After 16 and 52 weeks, significant improvements were observed in SNOT-22 (40.3 and 28.8), NPS (4.3 and 2.7), corticosteroid use, and complete eosinophil depletion. VAS scores improved, especially in smell, rhinorrhea, and general condition. No significant adverse events occurred. These preliminary results suggest that benralizumab may be effective in CRSwNP without associated asthma, although larger controlled studies are needed.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 6","pages":"Article 512291"},"PeriodicalIF":1.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efectividad del implante coclear unilateral en personas mayores de 60 años","authors":"Beatriz Tena-García ,&nbsp;Sergio Barrientos Trigo ,&nbsp;Francisco Ropero Romero ,&nbsp;Serafín Sánchez-Gómez","doi":"10.1016/j.otorri.2025.512285","DOIUrl":"10.1016/j.otorri.2025.512285","url":null,"abstract":"<div><h3>Background and objective</h3><div>Hearing loss is highly prevalent among older adults, affecting their quality of life. The aim of this study was to evaluate the audiological effectiveness of unilateral cochlear implantation (CI) in individuals over 60 years of age and to identify clinical and demographic factors influencing outcomes.</div></div><div><h3>Material and methods</h3><div>A single-center, longitudinal, observational, retrospective cohort study was conducted at a tertiary care hospital. Pure-tone average (PTA) thresholds and speech intelligibility (speech audiometry) were analyzed, complemented with the SSQ-12 and HISQUI-19 sound quality questionnaires. Non-parametric tests (Mann–Whitney, Kruskal–Wallis) were applied in the absence of normality, as well as Spearman's rho correlation and linear regression to examine associations between clinical and demographic variables and audiological outcomes.</div></div><div><h3>Results</h3><div>A cohort of 278 cochlear implant recipients aged 60 years or older was assessed. The final sample included 99 participants (71 implanted at ≥<!--> <!-->60 years after stratified random sampling; 28 implanted between 55–59 years). The mean implantation age was 67.7<!--> <!-->±<!--> <!-->5.8 years. The mean postoperative PTA was 37,65<!--> <!-->±<!--> <!-->10,71<!--> <!-->dB, with a functional gain of 63.6<!--> <!-->dB compared to preoperative levels. Mean speech intelligibility reached 53<!--> <!-->±<!--> <!-->24,57%. Although initial associations suggested that younger implantation age and shorter duration of auditory deprivation correlated with better audiological outcomes, subsequent regression analyses did not confirm a statistically significant independent association for these variables. Non-native Spanish language use was identified as a significant negative predictor of intelligibility. Poorer thresholds were associated with family history of hearing loss (p<!--> <!-->=<!--> <!-->0.01) and lower body mass index (p<!--> <!-->=<!--> <!-->0.005). Among complications (8.4%), the most relevant were three CI explantation/reimplantation cases (3%).</div></div><div><h3>Conclusions</h3><div>Unilateral cochlear implantation is highly effective in adults over 60 years, restoring functional hearing. Overall results are comparable to younger populations, supporting the indication of cochlear implantation in older adults. Speech intelligibility showed high interindividual variability, partially explained by non-native Spanish language use. Regression analysis showed that neither implantation age nor duration of auditory deprivation had an independent association with outcomes in this cohort, and therefore should not be considered contraindications for CI. The finding that 50.5% of cases had a family history of hearing loss suggests the need to expand genetic testing in adult CI candidates. The low complication rate (8.4%) confirms the safety of cochlear implantation.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 6","pages":"Article 512285"},"PeriodicalIF":1.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transoral CO2 laser microsurgery for early hypopharyngeal cancer: Still a viable option?","authors":"Carlos M. Chiesa-Estomba,&nbsp;Alfonso Rodriguez-Urzay,&nbsp;Maria Landa-Garmendia,&nbsp;Aitor Vargas-Alvarez,&nbsp;Ehkiñe Larruscain-Sarasola,&nbsp;Jose A. González-García,&nbsp;Maider Andueza-Guembe,&nbsp;Jon A. Sistaga-Suarez","doi":"10.1016/j.otorri.2025.512278","DOIUrl":"10.1016/j.otorri.2025.512278","url":null,"abstract":"<div><h3>Introduction</h3><div>Hypopharyngeal squamous cell carcinoma (HPSCC) is a highly aggressive malignancy with poor prognosis due to late-stage diagnosis and complex anatomical challenges. Advances in minimally invasive techniques, particularly transoral laser microsurgery (CO₂TOLMS), have demonstrated promise in improving oncologic and functional outcomes while preserving organ function.</div></div><div><h3>Materials and methods</h3><div>A retrospective study analyzed 25 patients with histologically confirmed HPSCC treated with CO₂TOLMS at a tertiary academic hospital (2016–2021). Patients underwent curative-intent CO₂TOLMS, with outcomes assessed for survival, recurrence, and functional recovery.</div></div><div><h3>Results</h3><div>The 3-year overall survival and disease-specific survival rates were 72% and 84%, respectively. Surgical margins were disease-free in 76% of patients, while postoperative complications were minimal (persistent tracheostomy in 4%, long-term nasogastric feeding tube dependency in 4%). Local and regional recurrence rates were each 8%. Laryngeal preservation was achieved in 95% of cases, significantly enhancing quality of life. Histologic grade correlated with recurrence risk, though survival outcomes were consistent across tumor stages and surgical margin status.</div></div><div><h3>Conclusions</h3><div>CO₂TOLMS offers an effective and minimally invasive treatment for early-stage HPSCC, achieving good oncological and functional outcomes. While it provides low morbidity and high organ preservation rates, further research is needed to refine multimodal treatment strategies for advanced-stage disease.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 6","pages":"Article 512278"},"PeriodicalIF":1.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eficacia y seguridad de la combinación cinarizina/dimenhidrinato frente a betahistina en el tratamiento del vértigo: revisión sistemática de la literatura","authors":"David Martín-Enguix ,&nbsp;Niceto Gómez Gabaldón ,&nbsp;Francisco J. Amaro-Gahete","doi":"10.1016/j.otorri.2025.512274","DOIUrl":"10.1016/j.otorri.2025.512274","url":null,"abstract":"<div><div>Vertigo is a frequent reason for medical consultation and may result from a wide range of etiologies. Betahistine and the fixed low-dose combination of cinnarizine 20<!--> <!-->mg and dimenhydrinate 40<!--> <!-->mg are commonly used therapeutic options, each with distinct antivertigo profiles. This systematic review, conducted in accordance with the PRISMA guidelines, aims to compare the efficacy and safety of these two treatments in patients with vertigo of various origins. A comprehensive search was conducted in PubMed, Cochrane Library, Google Scholar, and ClinicalTrials.gov, with no restrictions on language or publication date. Eligible studies included clinical trials and meta-analyses comparing the fixed low-dose combination (20<!--> <!-->mg/40<!--> <!-->mg) versus betahistine (12 or 16<!--> <!-->mg), assessing efficacy through the Mean Vertigo Score (MVS) and safety based on the incidence of adverse events (AEs). The RoB 2 and ROBIS tools were used to evaluate the risk of bias. A total of nine studies were identified (six clinical trials and three meta-analyses). In five of the six clinical trials, the fixed low-dose combination significantly reduced MVS compared with betahistine at weeks 1 and/or 4 (p<!--> <!-->&lt;<!--> <!-->0.05); these findings were corroborated by the three meta-analyses. Regarding safety, both treatments were well tolerated, with no serious AEs reported and a generally lower incidence observed in the fixed low-dose combination group. Overall, the fixed low-dose combination demonstrated superior clinical efficacy from the first week of treatment, along with a more favorable tolerability and safety profile. These results support its preferential use in the management of acute vestibular syndrome.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 6","pages":"Article 512274"},"PeriodicalIF":1.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Newborn nasal obstruction: Rare anatomical causes to consider","authors":"Montserrat Asensi-Diaz ,&nbsp;Alejandro Lowy Benoliel ,&nbsp;Juan Antonio Pasamontes Pingarron ,&nbsp;Ismael Nieva Pascual ,&nbsp;Pilar Cifuentes Canorea ,&nbsp;Monica Hernando Cuñado","doi":"10.1016/j.otorri.2025.512279","DOIUrl":"10.1016/j.otorri.2025.512279","url":null,"abstract":"<div><div>Neonatal nasal obstruction, though rare, can be life-threatening due to the obligate nasal breathing pattern in newborns. Even partial obstruction may compromise ventilation and feeding.</div><div>This study aims to describe rare anatomical causes of neonatal nasal obstruction, highlighting their clinical presentation, diagnostic evaluation, and management.</div><div>A retrospective review was conducted of four neonates with respiratory distress who were diagnosed with congenital nasal malformations through endoscopic examination and craniofacial imaging. The identified cases included bilateral choanal atresia in a patient with CHARGE syndrome, congenital nasal pyriform aperture stenosis (CNPAS) with a solitary median mega-incisor, isolated CNPAS with midnasal hypoplasia, and bilateral congenital dacryocystoceles. Symptoms ranged from noisy breathing to feeding intolerance. Management included both medical and surgical interventions depending on the severity of the obstruction.</div><div>Although infrequent, anatomical nasal anomalies should be promptly considered in neonates presenting with respiratory distress, as early diagnosis and appropriate treatment are essential to avoid complications and ensure favourable outcomes.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 6","pages":"Article 512279"},"PeriodicalIF":1.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validación del cuestionario de autoevaluación para pacientes con parálisis vocal unilateral (PVU-HI-10) en castellano","authors":"Rosa Hernández-Sandemetrio ,&nbsp;Natsuki Oishi ,&nbsp;Isabel López ,&nbsp;Cristina Rodríguez-Prado ,&nbsp;Isabel García-Lopez ,&nbsp;Enrique Zapater","doi":"10.1016/j.otorri.2025.512271","DOIUrl":"10.1016/j.otorri.2025.512271","url":null,"abstract":"<div><h3>Introduction and objective</h3><div>Unilateral vocal cord paralysis (UVCP) is a condition that directly affects laryngeal functions. While most cases have an organic cause, idiopathic cases have also been described. Patients with UVCP often experience symptoms that impact not only their vocal abilities but also their nutritional and social well-being. Our primary objective is to validate a self-assessment questionnaire for patients with UVCP and unilateral vocal immobility, incorporating questions that cover all possible symptoms of this condition, adapted to the Spanish spoken in Spain.</div></div><div><h3>Methodology</h3><div>This is a prospective observational study using the PVU-HI-10 questionnaire, which assesses the functional, physical, and emotional impact of UVCP-related symptoms. For validation, we statistically evaluated test-retest reliability, item-total correlation, internal consistency, concurrent validity, and discriminative validity, with sensitivity and specificity analysis. A total of 62 subjects participated: 33 patients (case group) and 29 healthy individuals (control group). All participants completed the PVU-HI-10 questionnaire twice, with a three-week interval between assessments and no treatment administered between them. The maximum phonation time (MPT) was used as the objective reference measure.</div></div><div><h3>Results</h3><div>The test-retest reliability was high, with an intraclass correlation coefficient (ICC) of 0.95. Internal consistency, measured using McDonald's omega coefficient, was 0.91 for the case group and 0.94 for the control group. The correlation between MPT and questionnaire scores was strong and inversely related (-0.61 and -0.67, respectively). Discriminative validity was demonstrated using the ROC curve, with a cutoff point of 12.1, yielding a sensitivity of 82% and a specificity of 93.1%.</div></div><div><h3>Conclusions</h3><div>In the management of unilateral vocal immobility, it is essential to consider the degree of disability caused by the symptoms. The PVU-HI-10 is a condition-specific questionnaire that has shown high reliability and validity. It is a brief, simple test that provides a numerical result, allowing for the quantification and comparison of treatment outcomes. This makes it a useful tool in the evaluation protocol for patients with unilateral vocal paralysis in Spanish-speaking populations.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 6","pages":"Article 512271"},"PeriodicalIF":1.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resultados de las versiones españolas del Cuestionario de otitis media crónica-12 (COMQ-12) y del Inventario de beneficios de otitis media crónica (COMBI) en pacientes y controles en nuestro medio","authors":"Alberto Codina ,&nbsp;Berta Alegre ,&nbsp;Elena Hernández-Montero ,&nbsp;Jorge Vega ,&nbsp;Miguel Caballero-Borrego ,&nbsp;Francisco Larrosa","doi":"10.1016/j.otorri.2025.512273","DOIUrl":"10.1016/j.otorri.2025.512273","url":null,"abstract":"<div><h3>Background and objective</h3><div>The Chronic Otitis Media Questionnaire-12 (COMQ-12) and the Chronic Otitis Media Benefits Inventory (COMBI) seek to assess the quality of life related to chronic otitis media or its surgical treatment. The objective of this study was to determine and evaluate the scores of the Spanish versions of the COMQ-12 and the COMBI.</div></div><div><h3>Materials and methods</h3><div>Multicenter retrospective study. Mean scores of the Spanish versions (COMQ-12-Spa and COMBI-Spa) were compared in consecutive adult patients diagnosed with chronic otitis media (COM), with or without cholesteatoma, undergoing tympanoplasty with and/or mastoidectomy and in a separate cohort of unaffected adults.</div></div><div><h3>Results</h3><div>120 patients and 60 unnaffected adults completed the study. The mean score of the COMQ-12-Spa in patients with COM and in healthy adults was 22.95<!--> <!-->±<!--> <!-->11.72 and 0.8<!--> <!-->±<!--> <!-->1.3 respectively (p &lt;<!--> <!-->0.0001). COMQ-12-Spa did not discriminate between COM without (21.9<!--> <!-->±<!--> <!-->10.45) and with cholesteatoma (23.82<!--> <!-->±<!--> <!-->9.53) (<em>P</em> <!-->&gt; 0.05). COMBI-Spa showed a mean postoperative score of 46.02<!--> <!-->±<!--> <!-->9.08 and was not able to discriminate between tympanoplasty without mastoidectomy (48.01<!--> <!-->±<!--> <!-->8.09) and mastoidectomy (45.32<!--> <!-->±<!--> <!-->10.03) (<em>P</em> <!-->&gt; 0.05).</div></div><div><h3>Conclusions</h3><div>The COMQ-12-Spa and the COMBI-Spa allow the pre- and post-intervention evaluation of the subjective severity of COM in adult patients in our setting, so their use is recommended.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 6","pages":"Article 512273"},"PeriodicalIF":1.1,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Speech discrimination and binaural processing in bilateral symmetric vs. asymmetric sensorineural hearing loss","authors":"Mai El Ghazaly,&nbsp;Esraa Meckawy,&nbsp;Hesham Kozou,&nbsp;Doaa Elmoazen","doi":"10.1016/j.otorri.2025.512265","DOIUrl":"10.1016/j.otorri.2025.512265","url":null,"abstract":"<div><h3>Purpose</h3><div>To investigate the effects of symmetric and asymmetric sensorineural hearing loss (SSNHL and ASNHL) on speech discrimination abilities and binaural processing, including integration and interaction.</div></div><div><h3>Materials and methods</h3><div>This cross-sectional study included 36 adult patients with bilateral sensorineural hearing loss, divided into two groups based on the symmetry of their hearing loss: ASNHL and SSNHL. Speech discrimination abilities were evaluated using the maximum speech discrimination score (SDSmax) with Arabic monosyllabic words. Binaural integration was assessed using the free-recall double dichotic digit test (DDT), while binaural interaction was evaluated through the binaural fusion test (BFT).</div></div><div><h3>Results</h3><div>The SDSmax of the worse-hearing ear in ASNHL patients (48.89 ± 10.13%) was significantly lower than in SSNHL patients (69.33 ± 7.97%) with comparable degrees of hearing loss. ASNHL patients exhibited a greater disparity between the better and worse-hearing ears in DDT scores (53.15 ± 13.98%) compared to SSNHL patients (22.96 ± 5.93%). Additionally, the BFT scores in ASNHL patients (55.14 ± 13.30%) were significantly lower than in SSNHL patients (72.92 ± 12.55%).</div></div><div><h3>Conclusions</h3><div>ASNHL patients experience greater impairments in speech discrimination, binaural integration, and interaction compared to SSNHL patients. These differences likely stem from auditory deprivation and asymmetry-induced deficits. Developing tailored hearing rehabilitation strategies is critical to addressing the unique challenges posed by asymmetric hearing loss.</div></div>","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 5","pages":"Article 512265"},"PeriodicalIF":1.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145108262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Aberrant intratympanic internal carotid artery","authors":"Saúl Astray-Gómez ,&nbsp;Celia Montón-Gómez ,&nbsp;Carlos de Paula-Vernetta","doi":"10.1016/j.otorri.2025.512268","DOIUrl":"10.1016/j.otorri.2025.512268","url":null,"abstract":"","PeriodicalId":7019,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 5","pages":"Article 512268"},"PeriodicalIF":1.1,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145108270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}